Nayak Sanjay (CIK 2012715) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-28). Recent activity: Sell OCUL (1,858 shares), Sell OCUL (1,759 shares), Sell OCUL (10,348 shares), Buy OCUL (64,900 shares), Sell OCUL (1,878 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-28 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Sell | 1,858 | $15,236 |
| 2026-02-25 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Sell | 1,759 | $14,565 |
| 2026-02-17 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Sell | 10,348 | $93,546 |
| 2026-01-06 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Buy | 64,900 | $0 |
| 2025-11-26 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Sell | 1,878 | $22,611 |
| 2025-08-27 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Sell | 1,885 | $22,695 |
| 2025-05-27 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | Sell | 1,862 | $13,351 |
Source: SEC Form 4 filings · as of 2026-05-28